Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839696 · ClinicalTrials.gov registry record
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 270
- Enrollment target
NCT00839696 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 270 participants.
The verdict
NCT00839696 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 270 participants
- Enrollment target
Study Summary
Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00839696
The ClinicalTrials.gov registry entry for NCT00839696 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00839696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00839696 about?
NCT00839696 is a clinical study titled "Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk". Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.
What is the current status of trial NCT00839696?
This trial is currently completed. The enrollment target is 270 participants. The study started on 2008-07. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00839696?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.